Plasma substance P level in patients with schizophrenia: A cross‐sectional study

Aspiration pneumonia is a serious health concern in older patients with schizophrenia. In this study, we examined clinical and demographic variables that could impact the plasma substance P level, which is a useful predictive biomarker of aspiration. Thirty‐four patients were included (mean age ± SD...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry and clinical neurosciences Vol. 65; no. 5; pp. 526 - 528
Main Authors Ishida, Takuto, Uchida, Hiroyuki, Suzuki, Takefumi, Nakajima, Shinichiro, Watanabe, Koichiro, Kashima, Haruo
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.08.2011
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aspiration pneumonia is a serious health concern in older patients with schizophrenia. In this study, we examined clinical and demographic variables that could impact the plasma substance P level, which is a useful predictive biomarker of aspiration. Thirty‐four patients were included (mean age ± SD: 70.9 ± 10.8 years). A greater number of cigarettes/day and a higher antipsychotic dosage were found to be associated with a lower plasma substance P level, while age showed a trend‐level effect. This finding suggests the need for intensive observation for prevention of aspiration pneumonia in heavy smokers who are receiving a higher antipsychotic dose in this senior population.
Bibliography:Conflicts of interest: All authors have nothing to disclose
No funding source was involved in this study
.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1323-1316
1440-1819
DOI:10.1111/j.1440-1819.2011.02244.x